farnaz shokraneh | personalized medicine | Best Researcher Award

Ms. farnaz shokraneh | personalized medicine | Best Researcher Award

Abo Akademi University, Finland

👨‍🎓Professional Profile 

Orcid Profile

👩‍🔬 Summary

Ms. Farnaz Shokraneh is an experienced pharmaceutical professional currently working as a Doctoral Researcher in Pharmaceutical Development and Medical Technology at Ă…bo Akademi University in Turku, Finland. With a solid academic background and extensive practical experience in pharmaceutical quality assurance, regulatory compliance, and research, she brings valuable insights into the development of pharmaceutical products and systems. She is committed to advancing personalized medicine and improving quality control in the pharmaceutical industry.

🎓 Education

Ms. Shokraneh holds a Doctor of Pharmacy degree, equivalent to a Finnish Master’s, from Islamic Azad University, Tehran, Iran (2007-2012). She furthered her academic journey with a Master’s in Pharmaceutical Research from Freie Universität Berlin, Germany (2022-2024). Currently, she is pursuing her doctoral research in Pharmaceutical Development and Medical Technology at Åbo Akademi University, Turku, Finland (2022–present).

đź’Ľ Professional Experience

Ms. Shokraneh has accumulated extensive experience in various roles within the pharmaceutical industry. She is currently serving as a Quality Manager at CurifyLabs Oy in Helsinki, Finland, since September 2022. Previously, she held the position of Quality Assurance Manager at Mofid Pharma under the license of Bayer Pharmaceutical Company (Dec 2020–Dec 2021). Additionally, she has worked at Modava Pharmaceutical under Novartis (Jul 2018–Jul 2020) and ATI Pharmed Pharmaceutical Co under StragenPharma and CHEMO Pharmaceutical licenses (Apr 2013–Jun 2017).

🛠️ Technical Skills

Ms. Shokraneh’s technical expertise encompasses pharmaceutical development, quality assurance, and regulatory compliance. She is proficient in analytical techniques such as HPLC, mass spectrometry, and micro NIR spectrophotometry. Her experience also extends to pharmacovigilance, safety monitoring, and statistical analysis for pharmaceutical applications, making her highly skilled in ensuring the safety, efficacy, and quality of pharmaceutical products.

🧑‍🏫 Teaching Experience

Although Ms. Shokraneh’s current focus is on research and industry roles, her vast knowledge and experience in the pharmaceutical field allow her to effectively mentor teams and share her expertise. She has contributed to the professional development of her colleagues and participated in educational training programs within the pharmaceutical sector.

🔬 Research Interests

Ms. Shokraneh’s primary research interests lie in pharmaceutical development and medical technology, with a particular focus on personalized medicine. She is passionate about improving drug safety and efficacy through innovations in automated pharmacy compounding, quality control, and exploring new methods for drug delivery and patient-specific treatment plans.

 

đź“–Top Noted Publications

Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets

Authors: Niklas Sandler Topelius, Farnaz Shokraneh, Mahsa Bahman, Julius Lahtinen, Niko Hassinen, Sari Airaksinen, Soumya Verma, Ludmila Hrizanovska, Jana Lass, Urve Paaver et al.

Journal: Pharmaceutics

Year: 2024

A Novel High Performance Liquid Chromatographic Method for Determination of Nystatin in Pharmaceutical Formulations by Box–Behnken Statistical Experiment Design

Authors: Farnaz Shokraneh

Journal: Iranian Journal of Pharmaceutical Research

Year: 2014

Comparative Studies of Cytotoxic Manufacturing Practices in Specialized Cancer Centers Against International Guidelines (ASHP, OSHA, HSE-UK)

Authors: Farnaz Shokraneh

Journal: FIP Congress

Year: 2012

Development and Validation of High-Performance Liquid Chromatography for Determination of Nystatin in Pharmaceutical Formulations

Authors: Farnaz Shokraneh

Journal: Research in Pharmaceutical Science

Year: 2012

A New HPLC Method for Determination of Losartan in Human Plasma and Its Application in Bioequivalence Studies

Authors: Farnaz Shokraneh

Journal: Oriental Journal of Chemistry

Year: 2012

Risks to Health Professionals from Hazardous Drugs in Iran: A Pilot Study of Understanding of Healthcare Team to Occupational Exposure to Cytotoxics

Authors: Farnaz Shokraneh

Journal: EXCLI Journal

Year: 2005

Yauba Saidu | Immunization financing | Best Researcher Award

Dr. Yauba Saidu | Immunization financing | Best Researcher Award

Dr. Yauba Saidu at Clinton health Access Initiative, Cameroon

👨‍🎓 Professional Profile

🌟 Current Position

Dr. Yauba Saidu serves as the Project Coordinator for the Building a National Medical Oxygen Strategy for Cape Verde and is also the Founder and President of the One Health Pastoral Initiative. In addition, he coordinates projects focused on strengthening human resources for health in the Central African Republic and protects chemotherapy drug quality in sub-Saharan Africa.

🎓 Early Academic Pursuits

Dr. Saidu earned his MD in General Medicine in 2007, followed by an MSc in Vaccinology and Pharmaceutical Clinical Development in 2011. He continued to enhance his expertise with a Ph.D. in Life Sciences (Global Health option) in 2023, and he recently completed a Certificate Program in One Health from the University of Florida in 2024.

đź’Ľ Professional Endeavors

Dr. Saidu’s career spans multiple high-impact roles in public health. Since 2021, he has been the Country Director for the Clinton Health Access Initiative in Cameroon, alongside his role as the National Coordinator for The Lancet NCDI Poverty Commission. His experience also includes significant positions at the Medical Research Council Unit in The Gambia and various roles in the Clinton Health Access Initiative, where he contributed to numerous health programs.

🔬 Contributions and Research Focus

With over 75 research papers and 2 book chapters to his name, Dr. Saidu has made significant contributions to global health, particularly in areas such as immunization services, chemotherapy drug quality, and public health strategies. His research emphasizes the intersection of health systems and the impact of non-communicable diseases in resource-limited settings.

🌍 Impact and Influence

Dr. Saidu’s work has garnered recognition, including his designation as a Knight of the Cameroon Order of Valor in 2022. His leadership in various health initiatives has had a profound impact on health outcomes in Cameroon and across sub-Saharan Africa.

đź“š Academic Cites

His research has received over 470 citations, achieving an H-index of 10, reflecting his influence in the field. His notable publications include contributions to vaccinology and climate change and health system sustainability.

🛠️ Technical Skills

Dr. Saidu possesses a diverse set of technical skills, including program management, clinical trial coordination, and expertise in vaccinology and public health policy. His ability to navigate complex health systems and drive initiatives for improved health access is a hallmark of his career.

👨‍🏫 Teaching Experience

As a student supervisor at the University of Buea, Dr. Saidu actively mentors the next generation of healthcare professionals, imparting his knowledge and experience in global health challenges.

🕊️ Legacy and Future Contributions

Dr. Saidu’s commitment to improving health outcomes in Africa positions him as a pivotal figure in global health. His ongoing projects aim to strengthen healthcare systems, expand access to essential medicines, and address the unique health challenges faced by vulnerable populations. As he continues to drive impactful health initiatives, Dr. Saidu is poised to leave a lasting legacy in the field of global health.

 

đź“– Top Noted Publications

 Anticipating and strategizing to address potential bottlenecks during clinical research projects in sub-Saharan Africa: a case for adapting approaches and tools used in the entrepreneurial and development sectors

Authors: Saidu, Y., Nchinjoh, S.C., Adidja, A., Ndom, P., Liebermann, M.
Journal: Trials
Year: 2024

Functional availability of medical oxygen for the management of hypoxaemia in Cameroon: A nationwide facility-based cross-sectional survey

Authors: Saidu, Y., Ndip, A.V., Diaby, O., Balkissou, A.D., Wiwa, O.
Journal: Journal of Global Health
Year: 2024

Climate change in Africa case studies: Role of healthcare and sustainable interventions

Authors: Umesi, A., Ubiame, O., Saidu, Y., Paul Jaiyeola, O., Darkwah, A.F.
Journal: Routledge Handbook of Climate Change and Health System Sustainability
Year: 2024

COVID-19 vaccination implementation in 52 African countries: trajectory and implications for future pandemic preparedness

Authors: Wariri, O., Afolabi, M.O., Mukandavire, C., Uthman, O.A., Kampmann, B.
Journal: BMJ Global Health
Year: 2023

The faces behind vaccination: unpacking the attitudes, knowledge, and practices of staff of Cameroon’s Expanded program on Immunization

Authors: Saidu, Y., Gu, J., Ngenge, B.M., Clemens, S.A.C., Clemens, R.
Journal: Human Resources for Health
Year: 2023

Assessment of immunization data management practices in Cameroon: unveiling potential barriers to immunization data quality

Authors: Saidu, Y., Gu, J., Ngenge, B.M., Clemens, S.A.C., Clemens, R.
Journal: BMC Health Services Research
Year: 2023

 Beyond the numbers: An in-depth look at Cameroon’s fifth national COVID-19 vaccination campaign through geographical and gender lenses

Authors: Amani, A., Njoh, A.A., Atuhebwe, P., Chaiban, T., Gueye, A.S.
Journal: Vaccine
Year: 2023